U
Sage Potash Corp. SAGE.V
TSX
Recommendation
--
Prev Close
$0.25
Volume
--
Avg Vol (90D)
105,932
Market Cap
$14.15M
Dividend & Yield
--
52-Week Range
$0.05 - $0.33
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
Sage Therapeutics (SAGE, $7.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 7, 2025
3/8/2025 - Tickeron - Stocks
FMR LLC Reduces Stake in Sage Therapeutics Inc: A Strategic Portfolio Adjustment
3/7/2025 - GuruFocus
Morgan Stanley Reduces Stake in Sage Therapeutics Inc
3/7/2025 - GuruFocus
Sage Therapeutics (SAGE, $7.55) price may drop as it broke higher Bollinger Band on Mar 05, 2025
3/6/2025 - Tickeron - Stocks
Sage Therapeutics (SAGE, $7.55) price may drop as it broke higher Bollinger Band on Mar 05, 2025
3/6/2025 - Tickeron - Stocks
Sage Therapeutics (SAGE, $7.55) price may drop as it broke higher Bollinger Band on Mar 05, 2025
3/6/2025 - Tickeron - Stocks
SAGE Therapeutics Announces CMO Resignation and Interim Appointment
3/4/2025 - TipRanks Financial Blog
Sage Therapeutics Announces R&D Leadership Transition
3/4/2025 - GuruFocus
Sage Therapeutics Chief Medical Officer to step down
3/4/2025 - The Fly
Sage Therapeutics Announces R&D Leadership Transition
3/4/2025 - Business Wire
12 Best Psychedelic Stocks to Buy in 2025
3/1/2025 - Insider Monkey
Sage Therapeutics price target established at JPMorgan
2/25/2025 - The Fly
10 Best Small-Cap Growth Stocks to Buy Now
2/24/2025 - Insider Monkey
Sage Therapeutics (SAGE, $7.04) price may climb as it broke lower Bollinger Band on Feb 19, 2025
2/20/2025 - Tickeron - Stocks
Short Interest in Sage Therapeutics, Inc. (NASDAQ:SAGE) Decreases By 32.0%
2/16/2025 - MarketBeat
Sage Therapeutics (NASDAQ:SAGE) Price Target Lowered to $8.00 at Canaccord Genuity Group
2/15/2025 - Ticker Report
RTW INVESTMENTS, LP Reduces Stake in Sage Therapeutics Inc
2/14/2025 - GuruFocus
Sage Therapeutics (NASDAQ:SAGE) Price Target Lowered to $12.00 at Scotiabank
2/13/2025 - MarketBeat
Wedbush Reaffirms Neutral Rating for Sage Therapeutics (NASDAQ:SAGE)
2/13/2025 - MarketBeat
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Values First Advisors Inc.
2/13/2025 - Ticker Report
SAGE Therapeutics Faces Legal Challenges: Potential Impact on Financial Stability and Growth
2/13/2025 - TipRanks Financial Blog
SAGE Therapeutics' Earnings Call: ZURZUVAE's Success Amid Challenges
2/13/2025 - TipRanks Financial Blog
Sage Therapeutics (NASDAQ:SAGE) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS
2/12/2025 - MarketBeat
Sage Therapeutics (NASDAQ:SAGE) Announces Earnings Results, Misses Estimates By $0.02 EPS
2/12/2025 - MarketBeat
FMR LLC Reduces Stake in Sage Therapeutics Inc: A Strategic Portfolio Adjustment
2/12/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
-1.14
7-Day Total Return
2.17%
30-Day Total Return
-9.62%
60-Day Total Return
14.63%
90-Day Total Return
14.63%
Year to Date Total Return
0.00%
1-Year Total Return
147.37%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 02, 2024 - $0.05
52-week High
Jun 06, 2024 - $0.33
Valuation
Market Cap
$14.15M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sagepotash.com
Phone Number
236 836 4182
Address
#605-899 West Pender Street
Vancouver, BC V6C 3B2
Country
Canada
Year Founded
2021
Business Description
Sector
Materials
Industry
Materials
Sage Potash Corp. engages in the acquisition, exploration, and development of mineral properties. It holds interest in the Sage Potash property located in the State of Utah. The company was... more
Weiss Ratings